Nogapendekin Alfa Inbakicept vs Tofacitinib

## Nogapendekin Alfa Inbakicept vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Nogapendekin Alfa Inbakicept** and **Tofacitinib**.

## Mechanism of Action

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Nogapendekin Alfa Inbakicept — N/A; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Nogapendekin Alfa Inbakicept — N/A; Tofacitinib — C16H20N6O.

**Molecular Weight**: Nogapendekin Alfa Inbakicept — N/A; Tofacitinib — 312.3700 g/mol.

**Type**: Nogapendekin Alfa Inbakicept — Protein; Tofacitinib — Small molecule.